ReviewBreast cancer research and treatment2024

Searching for the "Holy Grail" of breast cancer recurrence risk: a narrative review of the hunt for a better biomarker and the promise of circulating tumor DNA (ctDNA).

Lucy Gao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.